BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results

BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall in revenues.

Bristol-Myers Squibb Company Q2 2023 earnings infographicBristol-Myers Squibb Company Q2 2023 earnings infographic

Net income attributable to shareholders was $2.07 billion or $0.99 per share in the June quarter, compared to $1.42 billion or $0.66 per share in the comparable period of 2022. Adjusted profit, meanwhile, declined to $1.75 per share in Q2 from $1.93 per share in the prior-year period.

Second-quarter revenues decreased 6% from last year to $11.23 billion. Domestic revenues declined by 5%, and international revenues dropped by 8%.

Prior Performance

Related Post
whatsapp
line